![Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology in: Journal of Neurosurgery Volume 119 Issue 2 (2013) Journals Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology in: Journal of Neurosurgery Volume 119 Issue 2 (2013) Journals](https://thejns.org/view/journals/j-neurosurg/119/2/jns122329f5.jpg)
Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology in: Journal of Neurosurgery Volume 119 Issue 2 (2013) Journals
![Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology in: Journal of Neurosurgery Volume 119 Issue 2 (2013) Journals Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology in: Journal of Neurosurgery Volume 119 Issue 2 (2013) Journals](https://thejns.org/view/journals/j-neurosurg/119/2/jns122329f2.jpg)
Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology in: Journal of Neurosurgery Volume 119 Issue 2 (2013) Journals
![A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas | American Journal of Neuroradiology A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas | American Journal of Neuroradiology](https://www.ajnr.org/content/ajnr/35/6/1096/F1.large.jpg)
A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas | American Journal of Neuroradiology
![IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy](https://www.spandidos-publications.com/article_images/ijo/41/4/IJO-41-04-1325-g02.jpg)
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
![IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy](https://www.spandidos-publications.com/article_images/ijo/41/4/IJO-41-04-1325-g00.jpg)
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
![Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas - ScienceDirect Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0959804920303518-gr1.jpg)
Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas - ScienceDirect
![Frontiers Publishing Partnerships | Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas Frontiers Publishing Partnerships | Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas](https://www.frontierspartnerships.org/files/MyHome%20Article%20Library/10208/10208_Thumb_400.jpg)
Frontiers Publishing Partnerships | Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas
![Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas | SpringerLink Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00401-004-0861-z/MediaObjects/s00401-004-0861-zfmb1.gif)
Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas | SpringerLink
![Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma | Scientific Reports Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-59089-x/MediaObjects/41598_2020_59089_Fig3_HTML.png)
Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma | Scientific Reports
![Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients | Radiation Oncology | Full Text Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients | Radiation Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13014-020-01728-8/MediaObjects/13014_2020_1728_Fig3_HTML.png)
Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients | Radiation Oncology | Full Text
![Risk factors for early progression of diffuse low-grade glioma in adults | Chinese Neurosurgical Journal Risk factors for early progression of diffuse low-grade glioma in adults | Chinese Neurosurgical Journal](https://mednexus.org/cms/asset/cc75d357-e0fb-4cbc-8721-057a335906e2/s41016-022-00295-z.png)
Risk factors for early progression of diffuse low-grade glioma in adults | Chinese Neurosurgical Journal
![Three-Year Survival Rate in All Kinds of Glioma Tumors in One Institution Iran 2001-2010 - Iranian Journal of Neurosurgery Three-Year Survival Rate in All Kinds of Glioma Tumors in One Institution Iran 2001-2010 - Iranian Journal of Neurosurgery](https://irjns.org/files/site1/images/f1(4).jpg)
Three-Year Survival Rate in All Kinds of Glioma Tumors in One Institution Iran 2001-2010 - Iranian Journal of Neurosurgery
![Current Oncology | Free Full-Text | Diagnostic Approaches to Adult-Type Diffuse Glial Tumors: Comparative Literature and Clinical Practice Study Current Oncology | Free Full-Text | Diagnostic Approaches to Adult-Type Diffuse Glial Tumors: Comparative Literature and Clinical Practice Study](https://www.mdpi.com/curroncol/curroncol-30-00568/article_deploy/html/images/curroncol-30-00568-g001.png)
Current Oncology | Free Full-Text | Diagnostic Approaches to Adult-Type Diffuse Glial Tumors: Comparative Literature and Clinical Practice Study
![Kaplan–Meier survival curves for WHO grade II to III diffuse glioma... | Download Scientific Diagram Kaplan–Meier survival curves for WHO grade II to III diffuse glioma... | Download Scientific Diagram](https://www.researchgate.net/publication/327585832/figure/fig2/AS:962107709349896@1606395761800/Kaplan-Meier-survival-curves-for-WHO-grade-II-to-III-diffuse-glioma-stratified-by-TCGA.gif)
Kaplan–Meier survival curves for WHO grade II to III diffuse glioma... | Download Scientific Diagram
![Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery | Acta Neuropathologica Communications | Full Text Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery | Acta Neuropathologica Communications | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40478-017-0443-7/MediaObjects/40478_2017_443_Fig4_HTML.gif)